FDA Approval: Obesity Drug Race Update (Part II)

Date: Friday, May 18 · 12:30 AM - 1:30 AM UTC
Location: Online

Manifest Investing will run a two-part webcast on the drug approval process. Hosted by Hugh McManus, the presentation will focus on two drug applications awaiting approval by the Food and Drug Administration: Qnexa from Vivus, Inc. [NASDAQ:VVUS] and Lorqess from Arena Pharmaceuticals, Inc. [NASDAQ:ARNA]. Each drug addresses the growing problem of obesity and weight management.

The presentation will focus mainly on the drug approval process rather than on the companies themselves. Participants will be introduced to the FDA website and where to look for useful information; the approval process will be examined as well as other websites where useful information is often posted.

Each presentation will last for an hour with a portion of the time of the end of answers and questions. There will be a follow up discussion on the MI website.